New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
BioCardia, Inc.
BCDA
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

8M

Biotechnology

Next Earning date - 13 Nov 2024

8M

Biotechnology

Next Earning date - 13 Nov 2024

2.42USD
Shape0.02 ( 0.83%)
favorite-chart

Relative Strenght

6
favorite-chart

Volume Buzz

-97%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

90%

Quote Panel

Shape
Updated October 28, 2024
1W -6.92 % 1M -22.44 % 3M -23.66 % 1Y -57.62 %

Key Metrics

Shape
  • Market Cap

    8.47M


  • Shares Outstanding

    3.50M


  • Share in Float

    2.72M


  • Dividende

    0


  • Earning Date

    13 Nov 2024


  • Price Target

    2.42


  • Average Volume

    834970


  • Beta

    1.257


  • Range

    1.96-23.25


  • Industry

    Biotechnology


  • Website

    https://www.biocardia.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

19.80x

P/S Ratio

-2.32x

P/B Ratio

-0.6

Debt/Equity

-1999.8%

Net Margin

$-5.3

EPS

How BCDA compares to sector?

P/E Ratio

Relative Strength

Shape

BCDA

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$500K

Shape16567%

2025-Revenue

$1.27

Shape-44%

2025-EPS

$500K

Shape68%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Dawson James

downgrade

Previous: Not converted

2022-11-11

Now: Neutral

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.17
vs -0.16

Q4.22

arrow
arrow

N/A

-0.16
vs -0.21

Q1.23

arrow
arrow

N/A

-0.17
vs -0.19

Q2.23

arrow
arrow

N/A

-0.17
vs -0.14

Q3.23

arrow
arrow

N/A

-0.12
vs -0.17

Q4.23

arrow
arrow

N/A

-1.35
vs -0.16

Q1.24

arrow
arrow

N/A

-1.35
vs -0.17

Q2.24

arrow
arrow

N/A

-0.88
vs -0.17

Q3.24

arrow
arrow

N/A

-1.19
vs -0.12

Q4.24

arrow
arrow

N/A

-1.59
vs -1.35

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-74%

212K  vs 821K

Q4.22

arrow
arrow

+34%

106K  vs 79K

Q1.23

arrow
arrow

+7%

64K  vs 60K

Q2.23

arrow
arrow

-96%

43K  vs 974K

Q3.23

arrow
arrow

+68%

357K  vs 212K

Q4.23

arrow
arrow

-88%

13K  vs 106K

Q1.24

arrow
arrow

-14%

55K  vs 64K

Q2.24

arrow
arrow

-93%

3K  vs 43K

Q3.24

arrow
arrow

-44%

200K  vs 357K

Q4.24

arrow
arrow

+1592%

220K  vs 13K

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-75%

-0.75
vs -0.37

Q4.22

arrow
arrow

-62%

-0.62
vs -0.75

Q1.23

arrow
arrow

-184%

-1.84
vs -0.62

Q2.23

arrow
arrow

-209%

-2.09
vs -1.84

Q3.23

arrow
arrow

+390%

3.9
vs -2.09

Q4.23

arrow
arrow

+129%

1.29
vs 3.9

Q1.24

arrow
arrow

+100%

1
vs 1.29

Q2.24

arrow
arrow

+84%

0.84
vs 1

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

25

25
vs 26

-4%

Q4.22

arrow
arrow

28

28
vs 25

12%

Q1.23

arrow
arrow

26

26
vs 28

-7%

Q2.23

arrow
arrow

26

26
vs 26

NA

Q3.23

arrow
arrow

18

18
vs 26

-31%

Q4.23

arrow
arrow

25

25
vs 18

39%

Q1.24

arrow
arrow

22

22
vs 25

-12%

Q2.24

arrow
arrow

1

1
vs 22

-95%

Earnings Growth

Latest News